Aggressive and violent behaviour
We are committed to providing the best possible care to our patients and consumers. To do this, we need to ensure the safety of the people who provide that care.
https://www.thermh.org.au/your-care/hospital-care/what-you-need-to-know-up-front/aggressive-violent-behaviourThe Royal Melbourne Hospital is required to monitor all approved research until the completion of the project.
https://www.thermh.org.au/research/office-for-research/post-approval-project-management/post-approval-monitoringThe RMH and Peter Mac unveil new men’s possum skin cloak for patients News article
The RMH and Peter Mac unveiled the new men's possum skin cloak today.
https://www.thermh.org.au/news/rmh-and-peter-mac-unveil-new-mens-possum-skin-cloak-for-patientsWe have a dedicated team of specialist doctors, nurses, allied health professionals and support staff, available 24 hours a day.
https://www.thermh.org.au/services/intensive-care/about-icu/how-icu-worksIf you’re worried, we’re worried
If you are worried about any change, talk to your nurse or doctor. If you are still concerned then we have a simple process to assist.
https://www.thermh.org.au/your-care/hospital-care/your-hospital-stay/your-safety-is-our-priority/if-youre-worried-were-worriedThe LGBTIQA+ Patient Liaison team supports LGBTIQA+ safety and inclusion within the hospital environment. We work to improve the experience of all LGBTIQA+ patients, consumers and visitors throughout their hospital journey.
https://www.thermh.org.au/your-care/supporting-you/welcoming-lgbtiqa-peopleLigelizumab for chronic spontaneous urticaria Research study
A clinical trial to assess a new drug called ligelizumab for the treatment of chronic spontaneous urticaria (CSU).
https://www.thermh.org.au/research/clinical-trials-research-studies/ligelizumab-for-chronic-spontaneous-urticariaUltrasound is an imaging test that uses high frequency sound waves to produce detailed pictures of the inside of your body.
https://www.thermh.org.au/services/medical-imaging/learn-about-imaging/ultrasoundWorking with us offers you diverse and exciting opportunities and training programs to develop and progress your career.
https://www.thermh.org.au/services/pharmacy/work-with-pharmacyYou have the right to determine what is done to your body.
https://www.thermh.org.au/your-care/hospital-care/your-hospital-stay/consent-to-treatmentGrief and loss are part of life. It's important to realise that grieving is a normal process and that you may need some help while going through this period.
https://www.thermh.org.au/services/mental-health/learn-about/experiencing-mental-health-challenges/problems-with-grief-lossNew drug for moderate to severe hidradenitis suppurativa Research study
A clinical trial to assess the safety and effectiveness of a new drug for hidradenitis suppurativa.
https://www.thermh.org.au/research/clinical-trials-research-studies/new-drug-for-moderate-to-severe-hidradenitis-suppurativaThe Office for Research manages all aspects of internal and external funding administration for research purposes.
https://www.thermh.org.au/research/office-for-research/research-endeavoursLearn more about the breakthroughs and innovations first achieved at the Royal Melbourne Hospital.
https://www.thermh.org.au/about/about-the-rmh/our-history-and-archives/breakthroughs-and-milestonesOPT-302 with ranibizumab for neovascular age-related macular degeneration Research study
The ShORe trial aims to determine if the investigational medication OPT-302 will improve vision for people with wet age-related macular degeneration (AMD) when given in combination with ranibizumab, compared to ranibizumab alone.
https://www.thermh.org.au/research/clinical-trials-research-studies/shore-opt-302-with-ranibizumab-in-neovascular-age-related-macular-degenerationPalliative care research awarded $100,000 grant News article
New research to enhance the timeliness and responsiveness of care for palliative care patients has been awarded a $100,000 grant by the Avant Foundation.
https://www.thermh.org.au/news/palliative-care-research-awarded-100000-grantAddiction Medicine RMH Service
We provide support to inpatients of the RMH with drug and alcohol conditions.
https://www.thermh.org.au/services/addition-medicineNew surgical pathways helping patients return home sooner News article
Patients undergoing planned surgery will be able to return home sooner thanks to the support of our 'hospital in the home' service.
https://www.thermh.org.au/news/new-surgical-pathways-helping-patients-return-home-soonerStudy to understand risk of Alzheimer’s disease in middle-aged adults Research study
An Australian-first online study of psychological, lifestyle and genetic factors that increase risk of Alzheimer’s disease.
https://www.thermh.org.au/research/clinical-trials-research-studies/study-to-understand-risk-of-alzheimers-disease-in-middle-aged-adultsGeneral Nephrology RMH Service
We provide comprehensive treatment, care and support for people with acute and chronic kidney (renal) disease.
https://www.thermh.org.au/services/kidney-care/kidney-care-services/general-nephrology